Geode Capital Management’s Acurx Pharmaceuticals ACXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $74.8K | Sell |
|
|||||
|
2025
Q1 | $66.9K | Buy |
|
|||||
|
2024
Q4 | $119K | Hold |
|
|||||
|
2024
Q3 | $278K | Buy |
|
|||||
|
2024
Q2 | $293K | Buy |
|
|||||
|
2024
Q1 | $285K | Buy |
|
|||||
|
2023
Q4 | $430K | Buy |
|
|||||
|
2023
Q3 | $127K | Buy |
|
|||||
|
2023
Q2 | $205K | Hold |
|
|||||
|
2023
Q1 | $267K | Hold |
|
|||||
|
2022
Q4 | $307K | Buy |
|
|||||
|
2022
Q3 | $228K | Buy |
|
|||||
|
2022
Q2 | $43K | Buy |
|
|||||
|
2022
Q1 | $35K | Buy |
|